American Association for Cancer Research, Clinical Cancer Research, 6(26), p. 1203-1204, 2020
DOI: 10.1158/1078-0432.ccr-19-3813
Full text: Unavailable
Abstract T-cell recognizable p53 hotspot mutations offer opportunities for immunotherapy and immune monitoring. Recognition of p53 mutations by peripheral blood CD8 and CD4 T lymphocytes has been revealed. See related article by Malekzadeh et al., p. 1267